HCW Biologics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- HCW Biologics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- HCWB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001828673
Board of directors
-
Gary M. Winer · DirectorSince 2023
-
Hing C. Wong · Director · Chief Executive OfficerSince 2023
-
Lisa M. Giles · DirectorSince 2023
-
Rick S. Greene · DirectorSince 2023
-
Scott T. Garrett · DirectorSince 2023
Chief executives
Hing C. Wong
· Chief Executive Officer
Dates unknown
Board connections
2 of this board's directors also sit on 2 other boards.
- via Gary M. Winer
- via Lisa M. Giles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 20, 2024 | Hing C. Wong Director, Officer (Chief Executive Officer) | Grant or award | +739,288 | $1.40 | $1,035,003 |
| Feb 20, 2024 | Rick S. Greene Director | Grant or award | +35,714 | $1.40 | $50,000 |
| Feb 20, 2024 | Lisa M. Giles Director | Grant or award | +35,715 | $1.40 | $50,001 |
| Feb 20, 2024 | Scott T. Garrett Director | Grant or award | +142,858 | $1.40 | $200,001 |
| Feb 20, 2024 | Flowers Lee Officer (SVP of Business Development) | Grant or award | +71,429 | $1.40 | $100,001 |
| Feb 20, 2024 | Byam Rebecca Officer (Chief Financial Officer) | Grant or award | +760,714 | $1.40 | $1,065,000 |
| Dec 11, 2023 | Rhode Peter Officer (See Remarks) | Option exercise | +14,000 | $0.14 | $1,960 |
| Dec 8, 2023 | Flowers Lee Officer (SVP of Business Development) | Option exercise | +7,501 | $0.14 | $1,050 |
| Nov 17, 2023 | Rhode Peter Officer (See Remarks) | Option exercise | +15,000 | $0.14 | $2,100 |
| Oct 19, 2023 | Byam Rebecca Officer (Chief Financial Officer) | Option exercise | +47,249 | $0.14 | $6,615 |
| Sep 14, 2023 | Hing C. Wong Director, Officer (Chief Executive Officer) | Open-market purchase | +1,800 | $2.08 | $3,744 |
| Sep 14, 2023 | Gary M. Winer Director | Open-market purchase | +162 | $2.08 | $337 |
| Sep 14, 2023 | Gary M. Winer Director | Open-market purchase | +879 | $2.05 | $1,802 |
| Sep 13, 2023 | Gary M. Winer Director | Open-market purchase | +500 | $2.05 | $1,025 |
| Sep 13, 2023 | Byam Rebecca Officer (Chief Financial Officer) | Open-market purchase | +5,000 | $2.10 | $10,500 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.